IMHO rejection of the 584 has been priced into our stock price for quite some time. The positive movement is, again in my opinion, due to the developments in the health record business. I truly believe that with the pres elect making comments about the need for electronic med records we are well-positioned for future growth with or without the patents. Great job RG. Add to our recent acquisitions a souped up 336 and, well I think we can all imagine where that will lead. Again, all IMO.